Changes in brainstem serotonergic and dopaminergic cell populations in experimental and clinical Huntington's disease

Neuroscience

Volumn 238, Issue , 2013, Pages 71-81

  Jahanshahi, A ^a,e   Vlamings, R ^a,e   van Roon Mom, W M C ^b   Faull, R L M ^c   Waldvogel, H J ^c   Janssen, M L F ^a,e   Yakkioui, Y ^a,e   Zeef, D H ^a,e   Kocabicak, E ^d   Steinbusch, H W M ^a,e   Temel, Y ^a,e  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^e European Graduate School of Neuroscience   (Netherlands)

Author keywords

Dopamine and cell phenotype; Dorsal raphe nucleus; Huntington's disease; Serotonin

Indexed keywords

DOPAMINE; SEROTONIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL COUNT; CELL FUNCTION; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPAMINERGIC NERVE CELL; DORSAL RAPHE NUCLEUS; FEMALE; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL;

AGED; AGED, 80 AND OVER; ANIMALS; CELL COUNT; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; RAPHE NUCLEI; RATS; RATS, TRANSGENIC; SEROTONERGIC NEURONS;

EID: 84875109082     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.01.071     Document Type: Article

References (47)

1. Bezprozvanny I., Hayden M.R. Deranged neuronal calcium signaling and Huntington disease. Biochem Biophys Res Commun 2004, 322:1310-1317.
2. Bird E.D. Chemical pathology of Huntington's disease. Annu Rev Pharmacol Toxicol 1980, 20:533-551.
3. Bird E.D., Spokes E.G., Iversen L.L. Dopamine and noradrenaline in post-mortem brain in Huntington's disease and schizophrenic illness. Acta Psychiatr Scand Suppl 1980, 280:63-73.
4. Bjorklund A., Dunnett S.B. Dopamine neuron systems in the brain: an update. Trends Neurosci 2007, 30:194-202.
5. Borodinsky L.N., Belgacem Y.H., Swapna I., Sequerra E.B. Dynamic regulation of neurotransmitter specification: relevance to nervous system homeostasis. Neuropharmacology 2012, in press.
6. Caiazzo M., Dell'anno M.T., Dvoretskova E., Lazarevic D., Taverna S., Leo D., Sotnikova T.D., Menegon A., Roncaglia P., Colciago G., Russo G., Carninci P., Pezzoli G., Gainetdinov R.R., Gustincich S., Dityatev A., Broccoli V. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 2011, 476:224-227.
7. Cao C., Temel Y., Blokland A., Ozen H., Steinbusch H.W., Vlamings R., Nguyen H.P., von Horsten S., Schmitz C., Visser-Vandewalle V. Progressive deterioration of reaction time performance and choreiform symptoms in a new Huntington's disease transgenic rat model. Behav Brain Res 2006, 170:257-261.
8. Dahlstrom A., Fuxe K. Localization of monoamines in the lower brain stem. Experientia 1964, 20:398-399.
9. Dentel C., Palamiuc L., Henriques A., Lannes B., Spreux-Varoquaux O., Gutknecht L., Rene F., Echaniz-Laguna A., Gonzalez de Aguilar J.L., Lesch K.P., Meininger V., Loeffler J.P., Dupuis L. Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity. Brain 2013, 136:483-493.
10. Descarries L., Berthelet F., Garcia S., Beaudet A. Dopaminergic projection from nucleus raphe dorsalis to neostriatum in the rat. J Comp Neurol 1986, 249(511-520):484-515.
11. Dulcis D., Spitzer N.C. Reserve pool neuron transmitter respecification: novel neuroplasticity. Dev Neurobiol 2012, 72:465-474.
12. Fu W., Le Maitre E., Fabre V., Bernard J.F., David Xu Z.Q., Hokfelt T. Chemical neuroanatomy of the dorsal raphe nucleus and adjacent structures of the mouse brain. J Comp Neurol 2010, 518:3464-3494.
13. Haan E.A., Jennings I.G., Cuello A.C., Nakata H., Fujisawa H., Chow C.W., Kushinsky R., Brittingham J., Cotton R.G. Identification of serotonergic neurons in human brain by a monoclonal antibody binding to all three aromatic amino acid hydroxylases. Brain Res 1987, 426:19-27.
14. Haber S.N., Fudge J.L. The primate substantia nigra and VTA: integrative circuitry and function. Crit Rev Neurobiol 1997, 11:323-342.
15. Hendricks T.J., Fyodorov D.V., Wegman L.J., Lelutiu N.B., Pehek E.A., Yamamoto B., Silver J., Weeber E.J., Sweatt J.D., Deneris E.S. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 2003, 37:233-247.
16. Huntington Study Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993, 72:971-983.
17. Jahanshahi A., Vlamings R., Kaya A.H., Lim L.W., Janssen M.L., Tan S., Visser-Vandewalle V., Steinbusch H.W., Temel Y. Hyperdopaminergic status in experimental Huntington disease. J Neuropathol Exp Neurol 2010, 69:910-917.
18. Jakel R.J., Maragos W.F. Neuronal cell death in Huntington's disease: a potential role for dopamine. Trends Neurosci 2000, 23:239-245.
19. Jankovic J., Chen S., Le W.D. The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. Prog Neurobiol 2005, 77:128-138.
20. Joel D., Weiner I. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 2000, 96:451-474.
21. Kantor O., Temel Y., Holzmann C., Raber K., Nguyen H.P., Cao C., Turkoglu H.O., Rutten B.P., Visser-Vandewalle V., Steinbusch H.W., Blokland A., Korr H., Riess O., von Horsten S., Schmitz C. Selective striatal neuron loss and alterations in behavior correlate with impaired striatal function in Huntington's disease transgenic rats. Neurobiology of disease 2006, 22:538-547.
22. Krogias C., Eyding J., Postert T. Transcranial sonography in Huntington's disease. Int Rev Neurobiol 2010, 90:237-257.
23. Krogias C., Strassburger K., Eyding J., Gold R., Norra C., Juckel G., Saft C., Ninphius D. Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonography. J Psychiatry Neurosci 2011, 36:187-194.
24. Mann D.M. Subcortical afferent projection systems in Huntington's chorea. Acta Neuropathol 1989, 78:551-554.
25. Mason S.L., Barker R.A. Emerging drug therapies in Huntington's disease. Expert Opin Emerg Drugs 2009, 14:273-297.
26. McLaughlin B.A., Nelson D., Erecinska M., Chesselet M.F. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J Neurochem 1998, 70:2406-2415.
27. Moreno N., Bachy I., Retaux S., Gonzalez A. LIM-homeodomain genes as developmental and adult genetic markers of Xenopus forebrain functional subdivisions. J Comp Neurol 2004, 472:52-72.
28. Murphy D.L., Lesch K.P. Targeting the murine serotonin transporter: insights into human neurobiology. Nat Rev Neurosci 2008, 9:85-96.
29. Nguyen H.P., Kobbe P., Rahne H., Worpel T., Jager B., Stephan M., Pabst R., Holzmann C., Riess O., Korr H., Kantor O., Petrasch-Parwez E., Wetzel R., Osmand A., Von Horsten S. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. Hum Mol Genet 2006, 15:3177-3194.
30. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego.
31. Pfisterer U., Kirkeby A., Torper O., Wood J., Nelander J., Dufour A., Bjorklund A., Lindvall O., Jakobsson J., Parmar M. Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A 2011, 108:10343-10348.
32. Schmitz C., Hof P.R. Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach. J Chem Neuroanat 2000, 20:93-114.
33. Schmitz C, Hof PR (2005) Design-based stereology in neuroscience. Neuroscience 130:813-831.
34. Spokes E.G. Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue. Brain 1980, 103:179-210.
35. Steinbusch H.W. Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 1981, 6:557-618.
36. Stratford T.R., Wirtshafter D. Ascending dopaminergic projections from the dorsal raphe nucleus in the rat. Brain Res 1990, 511:173-176.
37. 2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc Natl Acad Sci U S A 2005, 102:2602-2607.
38. Tork I., Halliday G.M., Cotton R.G. Application of antiphenylalanine hydroxylase antibodies to the study of the serotonergic system in the human brain. J Chem Neuroanat 1992, 5:311-313.
39. Underwood M.D., Mann J.J., Arango V. Morphometry of dorsal raphe nucleus serotonergic neurons in alcoholism. Alcohol Clin Exp Res 2007, 31:837-845.
40. van Duijn E., Kingma E.M., Van der Mast R.C. Psychopathology in verified Huntington's disease gene carriers. J Neuropsychiatry Clin Neurosci 2007, 19:441-448.
41. Velazquez-Ulloa N.A., Spitzer N.C., Dulcis D. Contexts for dopamine specification by calcium spike activity in the CNS. J Neurosci 2011, 31:78-88.
42. Vitalis T., Cases O., Engelkamp D., Verney C., Price D.J. Defect of tyrosine hydroxylase-immunoreactive neurons in the brains of mice lacking the transcription factor Pax6. J Neurosci 2000, 20:6501-6516.
43. von Horsten S., Schmitt I., Nguyen H.P., Holzmann C., Schmidt T., Walther T., Bader M., Pabst R., Kobbe P., Krotova J., Stiller D., Kask A., Vaarmann A., Rathke-Hartlieb S., Schulz J.B., Grasshoff U., Bauer I., Vieira-Saecker A.M., Paul M., Jones L., Lindenberg K.S., Landwehrmeyer B., Bauer A., Li X.J., Riess O. Transgenic rat model of Huntington's disease. Hum Mol Genet 2003, 12:617-624.
44. Vonsattel J.P., DiFiglia M. Huntington disease. J Neuropathol Exp Neurol 1998, 57:369-384.
45. Waldvogel H.J., Curtis M.A., Baer K., Rees M.I., Faull R.L. Immunohistochemical staining of post-mortem adult human brain sections. Nat Protocols 2006, 1:2719-2732.
46. West M.J., Slomianka L., Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991, 231:482-497.
47. 2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease. Neurobiol Dis 2008, 31:80-88.